Pfizer Hits Teva With Suit Over Arthritis Drug Patent
Pfizer has sued Teva Pharmaceuticals in Delaware federal court for allegedly rushing to make a generic version of Pfizer's arthritis drug Xeljanz XR before a patent on the treatment expires....To view the full article, register now.
Already a subscriber? Click here to view full article